Review





Similar Products

166 ar tic le in pr es s human hcc cell lines hepg2  (ATCC)
99
ATCC 166 ar tic le in pr es s human hcc cell lines hepg2
166 Ar Tic Le In Pr Es S Human Hcc Cell Lines Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm42035177-71-5-30?v=ATCC
Average 99 stars, based on 1 article reviews
166 ar tic le in pr es s human hcc cell lines hepg2 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
pr es s igg  (Proteintech)
93
Proteintech pr es s igg
Pr Es S Igg, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41928272-83-9-14?v=Proteintech
Average 93 stars, based on 1 article reviews
pr es s igg - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
human es  (ATCC)
97
ATCC human es
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Human Es, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pmc13036157-39-1-13?v=ATCC
Average 97 stars, based on 1 article reviews
human es - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
culture human mm cell lines 140 accepted manuscript ar tic le in pr es s article in press  (ATCC)
96
ATCC culture human mm cell lines 140 accepted manuscript ar tic le in pr es s article in press
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Culture Human Mm Cell Lines 140 Accepted Manuscript Ar Tic Le In Pr Es S Article In Press, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41840398-40-3-22?v=ATCC
Average 96 stars, based on 1 article reviews
culture human mm cell lines 140 accepted manuscript ar tic le in pr es s article in press - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
cd45 hi30 standard biotools 3198001b 209bi cd11b mac 1 icrf44 standard biotools 3209003b ar tic le in pr es s  (fluidigm)
94
fluidigm cd45 hi30 standard biotools 3198001b 209bi cd11b mac 1 icrf44 standard biotools 3209003b ar tic le in pr es s
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Cd45 Hi30 Standard Biotools 3198001b 209bi Cd11b Mac 1 Icrf44 Standard Biotools 3209003b Ar Tic Le In Pr Es S, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41827061-244-284-286?v=fluidigm
Average 94 stars, based on 1 article reviews
cd45 hi30 standard biotools 3198001b 209bi cd11b mac 1 icrf44 standard biotools 3209003b ar tic le in pr es s - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
pr es s human hnscc cell lines scc25  (ATCC)
97
ATCC pr es s human hnscc cell lines scc25
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Pr Es S Human Hnscc Cell Lines Scc25, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41765937-100-8-25?v=ATCC
Average 97 stars, based on 1 article reviews
pr es s human hnscc cell lines scc25 - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
ar tic le in pr es s eel h5560  (Elabscience Biotechnology)
95
Elabscience Biotechnology ar tic le in pr es s eel h5560
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Ar Tic Le In Pr Es S Eel H5560, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41761383-85-23-20?v=Elabscience+Biotechnology
Average 95 stars, based on 1 article reviews
ar tic le in pr es s eel h5560 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
ar tic le in pr es s human periodontal ligament stem cells  (Galectin Therapeutics)
86
Galectin Therapeutics ar tic le in pr es s human periodontal ligament stem cells
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Ar Tic Le In Pr Es S Human Periodontal Ligament Stem Cells, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41721327-265-7-0?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
ar tic le in pr es s human periodontal ligament stem cells - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
differentiation ar tic le in pr es s human neuroblastoma sh sy5y cells  (ATCC)
99
ATCC differentiation ar tic le in pr es s human neuroblastoma sh sy5y cells
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Differentiation Ar Tic Le In Pr Es S Human Neuroblastoma Sh Sy5y Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41668094-67-4-16?v=ATCC
Average 99 stars, based on 1 article reviews
differentiation ar tic le in pr es s human neuroblastoma sh sy5y cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
pr es s article in press chrna1 proteintech human  (Proteintech)
94
Proteintech pr es s article in press chrna1 proteintech human
Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in <t>(A)</t> <t>ES-2</t> and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.
Pr Es S Article In Press Chrna1 Proteintech Human, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+es/pm41612506-569-6-14?v=Proteintech
Average 94 stars, based on 1 article reviews
pr es s article in press chrna1 proteintech human - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

Image Search Results


Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in (A) ES-2 and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.

Journal: Frontiers in Pharmacology

Article Title: Targeting in vitro vasculogenic mimicry and associated stemness transcriptional signature in human ovarian cancer cell models: new emerging roles of caffeic acid phenethyl ester synthetic analogs

doi: 10.3389/fphar.2026.1787101

Figure Lengend Snippet: Effects of CAPE (1) and its analogs (2–5) on in vitro vasculogenic mimicry in ovarian cancer cell models. Representative images and Wimasis-processed overlays of the impact of the vehicle, CAPE (1), and analogs (2–5) (1 μM) on capillary-like structure formation in (A) ES-2 and (B) SKOV3 ovarian cancer cells. (C) VM parameters for tube length, branching points, and total tubes for both ES-2 and SKOV3 cells under each treatment. VM parameters expressed as percent of control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus the vehicle (DMSO) with P < 0.05.

Article Snippet: The human ES-2 ovarian clear cell carcinoma cell line was purchased from the American Type Culture Collection (Manassas, VA, United States).

Techniques: In Vitro, Control

Synthetic ketone analogs (4) and (5) inhibit in vitro VM formation in a concentration-dependent manner. ES-2 cells were seeded on top of Matrigel in the presence of the indicated concentrations of analogs (4) or (5). (A) Representative phase-contrast images (upper panels) and corresponding Wimasis segmentation (lower panels) are shown. (B) Quantification of VM parameters, tube length, branching points, and total tubes expressed as percentage of the vehicle control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus vehicle (DMSO) with P < 0.05 (C) Cell chemotaxis in response to serum (left panel) and in response to the indicated concentrations of analogs (4) or (5). (D) ES-2 cells were treated with the indicated concentrations of (4) or (5) for 24 h. Cell viability was evaluated for each concentration using the Trypan Blue exclusion assay and a TC20 Automated Cell Counter (Biorad). Data are representative of two independent experiments.

Journal: Frontiers in Pharmacology

Article Title: Targeting in vitro vasculogenic mimicry and associated stemness transcriptional signature in human ovarian cancer cell models: new emerging roles of caffeic acid phenethyl ester synthetic analogs

doi: 10.3389/fphar.2026.1787101

Figure Lengend Snippet: Synthetic ketone analogs (4) and (5) inhibit in vitro VM formation in a concentration-dependent manner. ES-2 cells were seeded on top of Matrigel in the presence of the indicated concentrations of analogs (4) or (5). (A) Representative phase-contrast images (upper panels) and corresponding Wimasis segmentation (lower panels) are shown. (B) Quantification of VM parameters, tube length, branching points, and total tubes expressed as percentage of the vehicle control. Data are the mean ± SD of 3 independent experiments, and asterisks (*) indicate statistically significant differences versus vehicle (DMSO) with P < 0.05 (C) Cell chemotaxis in response to serum (left panel) and in response to the indicated concentrations of analogs (4) or (5). (D) ES-2 cells were treated with the indicated concentrations of (4) or (5) for 24 h. Cell viability was evaluated for each concentration using the Trypan Blue exclusion assay and a TC20 Automated Cell Counter (Biorad). Data are representative of two independent experiments.

Article Snippet: The human ES-2 ovarian clear cell carcinoma cell line was purchased from the American Type Culture Collection (Manassas, VA, United States).

Techniques: In Vitro, Concentration Assay, Control, Chemotaxis Assay, Trypan Blue Exclusion Assay